Asia-Pacific Prostate Cancer Market by Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy) and Brachytherapy (Permanent Brachytherapy and Temporary Brachytherapy)), by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Prostate Cancer Market by Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy) and Brachytherapy (Permanent Brachytherapy and Temporary Brachytherapy)), by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1619 | Pages: 141 | November 2016 | Region: Asia Pacific


The Asia-Pacific Prostate Cancer Market was worth $8.64 billion in 2016 and estimated to be growing at a CAGR of 10.65%, to reach $14.33 billion by 2021. Asia Pacific market is estimated to show substantial growth rate due to the presence of high unmet needs in the promising countries.

Prostate cancer is a common term used for diseased situation in which abnormal cells grow and infect in uncontrolled manner in the prostate. New products inventions, partnership agreements, collaborations and acquisitions are some of the key strategies adopted by the players to get large market share in the forecast period.

Advancement in technology, personalized medicine, cost effective treatment procedures are few other factors expected provide boost to Asia-Pacific prostate cancer market. Rising incidence of prostate cancers and availability of various treatment modalities are also fuelling the market growth. However, limited commercially availability drugs and treatments for this cancer is the challenge restraining the growth of prostate cancer market.

The Asia-Pacific Prostate Cancer market is segmented on the basis of diagnostic techniques into Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA). Based on surgery the market is segregated into Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR). By radiation therapy, the market is bifurcated into External Beam Radiation Therapy and Brachytherapy. External bean radiation therapy segment is further divided among 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy. Brachytherapy segment is sub segmented into Permanent Brachytherapy and Temporary Brachytherapy. On the basis of chemotherapy, segments are Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine.

Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China and India are estimated to grow at highest rate due to increasing cancer population.

Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  2. Asia-Pacific Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  9. Asia-Pacific External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  12. Asia-Pacific Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Etoposide Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  17. Japan Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  18. Japan Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  19. Japan Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  20. Japan Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  21. China Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  22. China Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  23. China Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  24. China Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  25. India Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  26. India Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  27. India Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  28. India Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  29. Australia Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  30. Australia Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  31. Australia Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  32. Australia Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  33. South Korea Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  34. South Korea Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  35. South Korea Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  36. South Korea Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  37. Asia-Pacific Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  38. Asia-Pacific 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  39. Asia-Pacific Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  40. Asia-Pacific Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  41. Asia-Pacific Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  42. Japan Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  43. China Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  44. India Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  45. Australia Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  46. Asia-Pacific Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  47. Asia-Pacific Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  48. Asia-Pacific Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  49. Japan Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  50. China Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  51. India Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  52. Australia Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.